Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASE Pain Trial: MDMA for Severe Chronic Neuropathic Pain
NCT07301632Phase 2Recruiting
- Sponsor
- Unity Health Toronto
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midomafetamine in chronic neuropathic pain, sponsored by Unity Health Toronto. Started Jan 2026; status: recruiting.
02
Drugs
midomafetamine
03
Conditions
chronic neuropathic pain
Beyond the preview
Go deeper on NCT07301632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07301632.